• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • William T. Cefalu, Lawrence A Leiter, Kun-Ho Yoon, Pablo Arias, Gary Meininger
  • Medicine
  • The Lancet
  • 2013 (First Publication: 14 September 2013)
  • BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve glycaemia in patients with type 2 diabetes by enhancing urinary glucose excretion. We compared the efficacy and safety ofExpand
  • Kaj Stenloef, William T. Cefalu, +5 authors Gary E Meininger
  • Medicine
  • Diabetes, obesity & metabolism
  • 2013 (First Publication: 24 January 2013)
  • Aims Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DMExpand
  • Lawrence A Leiter, William T. Cefalu, Tjerk W A de Bruin, Ingrid Anna Gause-Nilsson, Jennifer Sugg, Shamik J. Parikh
  • Medicine
  • Journal of the American Geriatrics Society
  • 2014 (First Publication: 1 July 2014)
  • OBJECTIVES To assess the efficacy of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, for the treatment of individuals with type 2 diabetes mellitus (T2DM) and preexisting cardiovascularExpand